Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) Restrict Oral Availability and Brain Accumulation of the PARP Inhibitor Rucaparib (AG-014699)
Crossref DOI link: https://doi.org/10.1007/s11095-014-1442-z
Published Online: 2014-06-25
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Durmus, Selvi
Sparidans, Rolf W.
van Esch, Anita
Wagenaar, Els
Beijnen, Jos H.
Schinkel, Alfred H.
Text and Data Mining valid from 2014-06-25